PROGRESSION OF MACULAR ATROPHY IN EYES WITH TYPE 1 NEOVASCULARIZATION AND AGE-RELATED MACULAR DEGENERATION RECEIVING LONG-TERM INTRAVITREAL ANTI–VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY: An Optical Coherence Tomographic Angiography Analysis

作者: Joseph G. Christenbury , Nopasak Phasukkijwatana , Fatimah Gilani , K. Bailey Freund , SriniVas Sadda

DOI: 10.1097/IAE.0000000000001766

关键词: OphthalmologyNeovascularizationAngiographyGrowth factorRetrospective cohort studyMacular atrophyMacular degenerationAtrophyAnti–vascular endothelial growth factor therapyMedicine

摘要: Purpose:To evaluate the size and location of macular atrophy in eyes with Type-1 neovascularization (NV) age-related degeneration receiving chronic intravitreal anti–vascular endothelial growth factor therapy.Methods:A retrospective review a case series 27 NV r

参考文章(33)
Veronika Vaclavik, Stela Vujosevic, Samantha S. Dandekar, Catey Bunce, Tunde Peto, Alan C. Bird, Autofluorescence Imaging in Age-Related Macular Degeneration Complicated by Choroidal Neovascularization Ophthalmology. ,vol. 115, pp. 342- 346 ,(2008) , 10.1016/J.OPHTHA.2007.04.023
Elona Dhrami-Gavazi, Chandrakumar Balaratnasingam, Winston Lee, K. Bailey Freund, Type 1 neovascularization may confer resistance to geographic atrophy amongst eyes treated for neovascular age-related macular degeneration International Journal of Retina and Vitreous. ,vol. 1, pp. 15- 26 ,(2015) , 10.1186/S40942-015-0015-6
Janet S. Sunness, Gary S. Rubin, Carol A. Applegate, Neil M. Bressler, Marta J. Marsh, Barbara S. Hawkins, David Haselwood, Visual Function Abnormalities and Prognosis in Eyes with Age-related Geographic Atrophy of the Macula and Good Visual Acuity Ophthalmology. ,vol. 104, pp. 1677- 1691 ,(1997) , 10.1016/S0161-6420(97)30079-7
James F. Vander, Craig M. Morgan, Howard Schatz, Growth Rate of Subretinal Neovascularization in Age-related Macular Degeneration Ophthalmology. ,vol. 96, pp. 1422- 1429 ,(1989) , 10.1016/S0161-6420(89)32740-0
K. L. Jin, X. O. Mao, D. A. Greenberg, Vascular endothelial growth factor: Direct neuroprotective effect in in vitro ischemia Proceedings of the National Academy of Sciences of the United States of America. ,vol. 97, pp. 10242- 10247 ,(2000) , 10.1073/PNAS.97.18.10242
Brandon G. Busbee, Allen C. Ho, David M. Brown, Jeffrey S. Heier, Ivan J. Suñer, Zhengrong Li, Roman G. Rubio, Phillip Lai, Twelve-month efficacy and safety of 0.5 mg or 2.0 mg ranibizumab in patients with subfoveal neovascular age-related macular degeneration. Ophthalmology. ,vol. 120, pp. 1046- 1056 ,(2013) , 10.1016/J.OPHTHA.2012.10.014
J P Sarks, S H Sarks, M C Killingsworth, Evolution of geographic atrophy of the retinal pigment epithelium. Eye. ,vol. 2, pp. 552- 577 ,(1988) , 10.1038/EYE.1988.106
grupo estudio VIEW2 HHO Dominguez, None, Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration. Ophthalmology. ,vol. 119, pp. 2537- 2548 ,(2012) , 10.1016/J.OPHTHA.2012.09.006